Literature DB >> 21640519

Impact of hypoxia on the metastatic potential of human prostate cancer cells.

Yao Dai1, Kyungmi Bae, Dietmar W Siemann.   

Abstract

PURPOSE: Intratumoral hypoxia is known to be associated with radioresistance and metastasis. The present study examined the effect of acute and chronic hypoxia on the metastatic potential of prostate cancer PC-3, DU145, and LNCaP cells. METHODS AND MATERIALS: Cell proliferation and clonogenicity were tested by MTT assay and colony formation assay, respectively. "Wound-healing" and Matrigel-based chamber assays were used to monitor cell motility and invasion. Hypoxia-inducible factor 1 alpha (HIF-1α) expression was tested by Western blot, and HIF-1-target gene expression was detected by real-time polymerase chain reaction. Secretion of matrix metalloproteinases (MMPs) was determined by gelatin zymography.
RESULTS: When PC-3 cells were exposed to 1% oxygen (hypoxia) for various periods of time, chronic hypoxia (≥24 h) decreased cell proliferation and induced cell death. In contrast, prostate cancer cells exposed to acute hypoxia (≤6 h) displayed increased motility, clonogenic survival, and invasive capacity. At the molecular level, both hypoxia and anoxia transiently stabilized HIF-1α. Exposure to hypoxia also induced the early expression of MMP-2, an invasiveness-related gene. Treatment with the HIF-1 inhibitor YC-1 attenuated the acute hypoxia-induced migration, invasion, and MMP-2 activity.
CONCLUSIONS: The length of oxygen deprivation strongly affected the functional behavior of all three prostate cancer cell lines. Acute hypoxia in particular was found to promote a more aggressive metastatic phenotype. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640519      PMCID: PMC3163803          DOI: 10.1016/j.ijrobp.2011.04.027

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  39 in total

Review 1.  HIF-1 as a target for drug development.

Authors:  Amato Giaccia; Bronwyn G Siim; Randall S Johnson
Journal:  Nat Rev Drug Discov       Date:  2003-10       Impact factor: 84.694

Review 2.  Exploiting tumour hypoxia in cancer treatment.

Authors:  J Martin Brown; William R Wilson
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

3.  Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors.

Authors:  R A Cairns; T Kalliomaki; R P Hill
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

Review 4.  pH, hypoxia and metastasis.

Authors:  R P Hill; K De Jaeger; A Jang; R Cairns
Journal:  Novartis Found Symp       Date:  2001

5.  BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro.

Authors:  Yao Dai; Dietmar W Siemann
Journal:  Mol Cancer Ther       Date:  2010-06-01       Impact factor: 6.261

6.  Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

Authors:  Selma Pennacchietti; Paolo Michieli; Maria Galluzzo; Massimiliano Mazzone; Silvia Giordano; Paolo M Comoglio
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

7.  Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma.

Authors:  Rob A Cairns; Richard P Hill
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

Review 8.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

9.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Authors:  H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

10.  Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia.

Authors:  O Thews; T Wolloscheck; W Dillenburg; S Kraus; D K Kelleher; M A Konerding; P Vaupel
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more
  34 in total

1.  Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules.

Authors:  Anand Ramteke; Harold Ting; Chapla Agarwal; Samiha Mateen; Ranganathan Somasagara; Anowar Hussain; Michael Graner; Barbara Frederick; Rajesh Agarwal; Gagan Deep
Journal:  Mol Carcinog       Date:  2013-12-17       Impact factor: 4.784

2.  Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells.

Authors:  Ana Belén Fernández-Martínez; Javier Lucio-Cazaña
Journal:  Cell Mol Life Sci       Date:  2015-04-01       Impact factor: 9.261

3.  Optical redox ratio identifies metastatic potential-dependent changes in breast cancer cell metabolism.

Authors:  Kinan Alhallak; Lisa G Rebello; Timothy J Muldoon; Kyle P Quinn; Narasimhan Rajaram
Journal:  Biomed Opt Express       Date:  2016-10-03       Impact factor: 3.732

4.  Characterizing prostate tumor mouse xenografts with CEST and MT-MRI and redox scanning.

Authors:  Kejia Cai; He N Xu; Anup Singh; Mohammad Haris; Ravinder Reddy; Lin Z Li
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 5.  Modulation of the tumor vasculature and oxygenation to improve therapy.

Authors:  Dietmar W Siemann; Michael R Horsman
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

Review 6.  Acute versus chronic hypoxia in tumors: Controversial data concerning time frames and biological consequences.

Authors:  C Bayer; P Vaupel
Journal:  Strahlenther Onkol       Date:  2012-03-29       Impact factor: 3.621

7.  Cathepsin L inhibition by the small molecule KGP94 suppresses tumor microenvironment enhanced metastasis associated cell functions of prostate and breast cancer cells.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Clin Exp Metastasis       Date:  2013-06-09       Impact factor: 5.150

8.  Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model.

Authors:  Chen Ling; Yuan Wang; Yuanhui Zhang; Anila Ejjigani; Zifei Yin; Yuan Lu; Lina Wang; Meng Wang; Jun Li; Zhongbo Hu; George V Aslanidi; Li Zhong; Guangping Gao; Arun Srivastava; Changquan Ling
Journal:  Hum Gene Ther       Date:  2014-12       Impact factor: 5.695

9.  Angiopoietin-like protein 2 is an important facilitator of tumor proliferation, metastasis, angiogenesis and glycolysis in osteosarcoma.

Authors:  Xiuhui Wang; Zhaohui Hu; Zhe Wang; Yin Cui; Xu Cui
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

10.  Targeting aurora kinase A inhibits hypoxia-mediated neuroblastoma cell tumorigenesis.

Authors:  Carmelle V Romain; Pritha Paul; Sora Lee; Jingbo Qiao; Dai H Chung
Journal:  Anticancer Res       Date:  2014-05       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.